• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

David J. Kuter, MD, DPhil


  • Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J.A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia.Blood. 2014 May 6.
  • Makar RS, Zhukov OS, Sahud MA, Kuter DJ.Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.Am J Hematol. 2013 Dec;88(12):1041-4.
  • Crawford J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Steensma DP, Talbott M, Vadhan-Raj S, Westervelt P, Westmoreland M, Dwyer M, Ho M.Myeloid growth factors.J Natl Compr Canc Netw. 2013 Oct 1;11(10):1266-90.
  • Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, Viallard JF, Macik G, Rummel M, Nie K, Jun S.Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.British Journal of Haematology. 2013 May;161(3):411-23.
  • Schulman S, Awad MM, Kuter DJ.Neutrophil-erythrocyte rosettes in autoimmune hemolytic anemia.Am J Hematol. 2012 Jun 8.
  • Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP.Romiplostim or standard of care in patients with immune thrombocytopenia.N Engl J Med. 2010 Nov 11;363(20):1889-99.
  • Kuter DJ.Romiplostim.Cancer Treat Res. 2011;157:267-88. Review.
  • Lennerz JK, Kuter DJ, Hasserjian R, Iafrate J.Massive hepatomegaly and involvement by Janus kinase 2-positive myeloproliferative neoplasm.Hepatology. 2010 Nov;52(5):1855-6.
  • Davids MS, Murali MR, Kuter DJ.Serum free light chain analysis.Am J Hematol. 2010 Oct;85(10):787-90. Review.
  • Rabin DU, Kuter DJ, Liebman HA, Bussel JB.What do healthcare providers ask their patients with immune thrombocytopenia?.Am J Hematol. 2010 Aug;85(8):629-31.
  • Kuter DJ.Biology and chemistry of thrombopoietic agents.Semin Hematol. 2010 Jul;47(3):243-8.
  • Bussel JB, Kuter DJ.New thrombopoietic agents: introduction.Semin Hematol. 2010 Jul;47(3):211.
  • Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ.International consensus report on the investigation and management of primary immune thrombocytopenia.Blood. 2010 Jan 14;115(2):168-86. Review.
  • Fleischmann KH, Kuter DJ, Coley CM, Rathmell JP.Practice guidelines often fail to keep pace with the rapid evolution of medicine: a call for clinicians to remain vigilant and revisit their own practice patterns.Reg Anesth Pain Med.;35(1):4-7.
  • Kuter DJ, Gernsheimer TB.Thrombopoietin and platelet production in chronic immune thrombocytopenia.Hematol Oncol Clin North Am. 2009 Dec;23(6):1193-211. Review.
  • Kuter DJ, Mufti GJ, Bain BJ, Hasserjian RP, Davis W, Rutstein M.Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim.Blood. 2009 Oct 29;114(18):3748-56.
  • Kuter DJ.Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia.Annu Rev Med. 2009;60:193-206. Review.
  • Richardson PG, Xie W, Mitsiades C, Chanan-Khan AA, Lonial S, Hassoun H, Avigan DE, Oaklander AL, Kuter DJ, Wen PY, Kesari S, Briemberg HR, Schlossman RL, Munshi NC, Heffner LT, Doss D, Esseltine DL, Weller E, Anderson KC, Amato AA.Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy.J Clin Oncol. 2009 Jul 20;27(21):3518-25.
  • Davis AK,Makar RS,Stowell CP,Kuter DJ,Dzik WH.ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13.Transfusion. 2009 Feb;49(2):206-13.
  • Bussel JB,Kuter DJ,Pullarkat V,Lyons RM,Guo M,Nichol JL.Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.Blood. 2009 Mar 5;113(10):2161-71.
  • Kuter DJ.Thrombopoietin and Thrombopoietin Mimetics in the Treatment of Thrombocytopenia.Annu Rev Public Health. 2008 Oct 31.
  • Kuter DJ.New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.Eur J Haematol Suppl. 2008 Feb(69):9-18. Review.
  • Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP.Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.British Journal of Haematology. 2007 Nov;139(3):351-62. Review.
  • Moore A, Lau E, Yang C, Mackool B, Kuter DJ.Dalteparin-induced skin necrosis in a patient with metastatic lung adenocarcinoma.Am J Clin Oncol. 2007 Jun;30(3):329-31.
  • Park JH, Spitzer T, Kuter DJ.Successful treatment of pure red cell aplasia with autologous stem cell transplantation.Am J Hematol. 2007 Sep;82(9):812-4.
  • Kuter DJ.The promise of thrombopoietins in the treatment of ITP.Clin Adv Hematol Oncol. 2005 Jun;3(6):464-6.
  • Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA.Effects of biochemically confirmed smoking cessation on white blood cell count.Mayo Clin Proc. 2005 Aug;80(8):1022-8.
  • Rosovsky RP, Kuter DJ.Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management.Hematol Oncol Clin North Am. 2005 Feb;19(1):183-202, vii.
  • Burstein HJ, Harris LN, Gelman R, Lester SC, Nunes RA, Kaelin CM, Parker LM, Ellisen LW, Kuter I, Gadd MA, Christian RL, Kennedy PR, Borges VF, Bunnell CA, Younger J, Smith BL, Winer EP.Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study.J Clin Oncol. 2003 Jan 1;21(1):46-53.
  • Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, Roche M, Powell SN.Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.J Natl Cancer Inst. 2001 Dec 5;93(23):1806-11.
  • Li J, Xia Y, Kuter DJ.Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics.Br J Haematol. 1999 Aug;106(2):345-56.